Fact CheckerSign in

NCT06709209Recruiting

AI-driven Narrow-band Imaging Score for Disease Assessment and Outcome Prediction in Ulcerative Colitis

A Novel Simplified Endoscopic Score aiMed at Evaluating Ulcerative cOlitis Activity Through TXI, RDI and NBI Vascular Assessment and at prEdicting Clinical Outcome and Its Applicability in an arTificial Intelligence System: the MONET Study

Source: ClinicalTrials.gov · Last updated 3 Dec 2024 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

This international multicentre prospective study aims to develop a new simple score using enhanced endoscopic techniques which focus on the vascular features of the colon and reliably distinguish between a quiescent and a mild inflammation in ulcerative colitis (UC). The diagnostic performance of the new score in defining disease activity/remission compared to existing endoscopic and histological scores and predict long-term clinical outcomes will be evaluated. The study also aims to adapt current artificial intelligence (AI) algorithms for enhanced endoscopic techniques to improve standardization in UC disease assessment and outcome prediction.

Status (registry)
Recruiting
Study type
Observational
Enrollment
300 (estimated)
First submitted
25 Nov 2024
Start date
4 Nov 2024
Primary completion date
30 Sept 2026
Lead sponsor
University College Cork
NCT number
NCT06709209

What you commit to

  • Study type: Observational
  • Planned participants: 300
  • From 4 Nov 2024 to the primary completion date, 30 Sept 2026
  • 11 sites in 6 countries
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • If the participant has been in a recent experimental trial, these must have been completed not less than thirty days prior to this study

Other

  • Contraindications to endoscopy (including toxic megacolon) and biopsies (including severe coagulopathy/thrombocytopenia)
  • Poor bowel preparation (defined as total BBPS \<6 or BBPS \<2 in observed segment for sigmoidoscopy)
  • Significant co-morbidities limiting life expectancy and conferring high risk of endoscopy
  • Pregnant and breast-feeding subjects
  • Inability to provide informed consent

Who the study is looking for

  • Adult patients aged 18 to 75 years old
  • Established diagnosis of UC (for at least six months in duration), independently from their active treatment
  • Undergoing endoscopy for disease activity assessment or cancer surveillance.

Age in the registry: 18 years to 75 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (11)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University of Leuven
Coordinator of this site? Confirm its status
LeuvenBelgiumNot yet recruiting
Klinikum Luneburg
Coordinator of this site? Confirm its status
LüneburgGermanyNot yet recruiting
University College Cork
Coordinator of this site? Confirm its status
CorkIrelandRecruiting
University of Bari
Coordinator of this site? Confirm its status
BariItalyNot yet recruiting
Ospedale S. Maria del Prato
Coordinator of this site? Confirm its status
FeltreItalyNot yet recruiting
Istituto Clinico Humanitas
Coordinator of this site? Confirm its status
MilanItalyNot yet recruiting
University Vita-Salute San Raffaele
Coordinator of this site? Confirm its status
MilanItalyNot yet recruiting
University of Naples
Coordinator of this site? Confirm its status
NaplesItalyRecruiting
University of Pavia
Coordinator of this site? Confirm its status
PaviaItalyNot yet recruiting
Showa University
Coordinator of this site? Confirm its status
TokyoJapanNot yet recruiting
Changi General Hospital
Coordinator of this site? Confirm its status
SingaporeSingaporeNot yet recruiting

This page is information, not medical advice. Discuss any trial with your doctor.